Yana iya ƙaddamar da ciwon gwiwa gwiwa
Sakamakon binciken da aka bayar a cikin fitowar ta Yuli 2005 na Arthritis & Rheumatism ya nuna cewa magani tare da kwayoyin cutar doxycycline na iya rage yawan ciwon osteoarthritis . Doxycycline ne kwayoyin da ke cikin likita da ake kira tetracyclines.
Game da Nazarin Doxycycline na shekarar 2005
Masu bincike sun kwatanta yin amfani da doxycycline zuwa placebo, bayan sunaye fiye da 400 matan da ke da ciwon gindin gwiwa a matsayin masu karatu.
Mahalarta masu nazarin sun shiga cikin kungiyoyi biyu, suna karɓar nauyin 100 mg na doxycycline sau biyu a kowace rana ko wuribo na har zuwa shekaru 2.5. Masu bincike sun bincikar tasirin doxycycline a kan mahaɗin haɗin gwiwa na gwiwa da aka shafa.
Bayan kimanin watanni 16 na jiyya, sakamakon ya nuna cewa asarar asarar haɗin gwiwar a cikin gwiwar da aka shafa yana da kashi 40 cikin dari a tsakanin mahalarta masu daukar doxycycline fiye da wadanda suka dauki wuribo. A ƙarshen shekaru biyu da rabi, asarar haɗin gwiwar ya kasance 33% kasa a cikin rukuni wanda ya dauki doxycyline fiye da a cikin placebo kungiyar. Doxycycline kuma yana hade da rashin haƙuri-ya ruwaito rahoton ƙarar zafi. Masu bincike sun yarda, cewa, matsanancin ciwo ba shi da kyau a cikin ƙungiyoyi biyu.
Nazarin shekarar 2005 shine karo na farko na nazarin doxycycline a matsayin magani mai mahimmanci don osteoarthritis. A lokacin, an ce ana bukatar karin nazarin don tabbatar da sakamakon.
Comments Daga Dr. Zashin
A kan batun doxycycline da osteoarthritis, masanin ilimin rheumatologist Scott Zashin, MD ya yi sharhi, "Da farko, wannan binciken ne na musamman a cikin cewa yana da nazari na tsawon lokaci wanda yake kallon magani ba kawai don taimakawa ciwo ba, amma kuma ya hana cigaba na osteoarthritis na gwiwa.
Duk da yake binciken bai nuna a fili cewa maganin doxycycline na maganin ya kasance mai tasiri a rage rage ba, akwai shaida cewa akwai ci gaba da ciwon osteoarthritis (watau, rashin asarar kayan tiyata) a marasa lafiya a kan kwayoyin. Mawallafa sun bayyana a fili cewa an yi amfani da maganin kwayoyin halitta don yin aiki bisa ga kayan kariya na inflammatory , kuma ba saboda sakamakonsa na antibacterial ba. "
Dr. Zashin ya ci gaba, "Menene wannan binciken yake nufi ga marasa lafiya da maganin osteoarthritis? Abubuwa biyu na asibiti da ke da mahimmanci ga marasa lafiya da likitoci sun hada da ko magani ya sauya rashin jin daɗin jiki kuma ko mai haƙuri zai iya buƙatar canji tare da juna a nan gaba. , yana da wuyar bayar da shawarar doxycyline na dogon lokaci don taimako daga bayyanar cututtuka . A gefe guda, yana yiwuwa marasa lafiya da ke shan maganin kwayoyin halitta na iya ƙila su buƙaci maye gurbin juna a nan gaba saboda ragewa a haɗin haɗuwa a kan radiyo. Abin baƙin ciki shine, don amsa wannan tambaya, za a buƙaci nazarin da ya fi tsayi.Yan tambayoyi da za a yi la'akari da shi ko marasa lafiya za su buƙaci kasancewa a kan maganin rigakafi har abada don taimakawa wajen rage lalacewar haɗin gwiwa kuma su hana maye gurbin haɗin gwiwa da kuma wace tasiri ne mai tasiri daga wannan dogon lokaci, tsarin mulki lokaci.
Tambayar ita ce ko yin amfani da miyagun kwayoyi 30 ko a'a, a kanta, zai rage chances cewa a cikin lokaci mai tsawo, marasa lafiya zasu iya yin aikin tiyata. Da fatan, wannan rukuni na marasa lafiya na iya ci gaba da karatu a nan gaba don taimakawa wajen amsa tambayoyin. "
2012 Cochrane Review of Doxycycline for Osteoarthritis
A shekara ta 2012, an sake sabuntawa na binciken Cochrane na doxycycline don maganin osteoarthritis da aka buga a 2009. Binciken ya yi la'akari da shaida a littattafan likita wanda ya bincika tasirin doxycycline a kan ciwo da aikin jiki a marasa lafiya da osteoarthritis na hip ko gwiwa lokacin da aka kwatanta to placebo.
Makarantun biyu ne kawai da aka kwashe 663 suka sami dacewa kuma sun hada da su a cikin wannan bita. Binciken ya tabbatar da cewa tasirin doxycycline a kan bayyanar cututtuka na ciwon osteoarthritis ba ƙari ba ne. Mahalarta masu nazarin sune ciwon ciwo kamar 1.9 a kan sikelin 0 (babu zafi) zuwa 10 (zafi mai tsanani) idan aka kwatanta da ingantaccen maki 1.8 ga marasa lafiya na wuribo bayan watanni 18.
Sakamakon binciken ya kuma bayyana cewa tasirin doxycycline akan aiki na jiki ba ƙari ba ne. Ci gaba a cikin aikin jiki shine kawai 1.4 zuwa 1.2 points a kan ma'auni 10 na mahalarta waɗanda suka dauki doxycycline da placebo, daidai da haka.
An kuma lura a cikin bita cewa kashi 20 cikin dari na mahalarta suka dauki nau'in sakamako na cututtukan kwayoyin cuta (kowane nau'in) idan aka kwatanta da 15% na wadanda suka dauki wuribo. Daga qarshe, amfani da doxycycline dangane da asarar haɗin sararin samaniya wanda aka ruwaito shi a farkon shi ya kasance kadan ne kuma yana da mahimmanci asibiti a cikin nazarin Cochrane.
> Sources:
> Hanyoyin Doxycycline a Ci gaba na Osteoarthritis: Sakamako na Randomized, Sanya-Sarrafawa, Ƙoƙwalwar Bincike Sau Biyu. Brandt KD et al. Arthritis & Rheumatology. Yuli 2005.
> Doxycycline for Osteoarthritis na Knee ko Hip. da Costa BR et al. Cochrane Library. Nuwamba 2012.